| pubmed-article:10908083 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10908083 | lifeskim:mentions | umls-concept:C0035173 | lld:lifeskim |
| pubmed-article:10908083 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:10908083 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
| pubmed-article:10908083 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:10908083 | lifeskim:mentions | umls-concept:C0028351 | lld:lifeskim |
| pubmed-article:10908083 | lifeskim:mentions | umls-concept:C0042402 | lld:lifeskim |
| pubmed-article:10908083 | lifeskim:mentions | umls-concept:C0015772 | lld:lifeskim |
| pubmed-article:10908083 | lifeskim:mentions | umls-concept:C0027481 | lld:lifeskim |
| pubmed-article:10908083 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:10908083 | pubmed:dateCreated | 2000-11-2 | lld:pubmed |
| pubmed-article:10908083 | pubmed:abstractText | Reflex activation of the sympathetic nervous system by short-acting dihydropyridine calcium channel antagonists has been reported to harm hypertensive patients. Different neurohormonal profiles and their response to treatment may influence the effectiveness of dihydropyridine vasodilator treatment of heart failure. | lld:pubmed |
| pubmed-article:10908083 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10908083 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10908083 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10908083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10908083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10908083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10908083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10908083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10908083 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10908083 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:10908083 | pubmed:issn | 1071-9164 | lld:pubmed |
| pubmed-article:10908083 | pubmed:author | pubmed-author:CohnJ NJN | lld:pubmed |
| pubmed-article:10908083 | pubmed:author | pubmed-author:SmithR FRF | lld:pubmed |
| pubmed-article:10908083 | pubmed:author | pubmed-author:WongMM | lld:pubmed |
| pubmed-article:10908083 | pubmed:author | pubmed-author:TaylorW RWR | lld:pubmed |
| pubmed-article:10908083 | pubmed:author | pubmed-author:AnandI SIS | lld:pubmed |
| pubmed-article:10908083 | pubmed:author | pubmed-author:ZiescheSS | lld:pubmed |
| pubmed-article:10908083 | pubmed:author | pubmed-author:JuddDD | lld:pubmed |
| pubmed-article:10908083 | pubmed:author | pubmed-author:GermansonTT | lld:pubmed |
| pubmed-article:10908083 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10908083 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:10908083 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10908083 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10908083 | pubmed:pagination | 97-107 | lld:pubmed |
| pubmed-article:10908083 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:10908083 | pubmed:meshHeading | pubmed-meshheading:10908083... | lld:pubmed |
| pubmed-article:10908083 | pubmed:meshHeading | pubmed-meshheading:10908083... | lld:pubmed |
| pubmed-article:10908083 | pubmed:meshHeading | pubmed-meshheading:10908083... | lld:pubmed |
| pubmed-article:10908083 | pubmed:meshHeading | pubmed-meshheading:10908083... | lld:pubmed |
| pubmed-article:10908083 | pubmed:meshHeading | pubmed-meshheading:10908083... | lld:pubmed |
| pubmed-article:10908083 | pubmed:meshHeading | pubmed-meshheading:10908083... | lld:pubmed |
| pubmed-article:10908083 | pubmed:meshHeading | pubmed-meshheading:10908083... | lld:pubmed |
| pubmed-article:10908083 | pubmed:meshHeading | pubmed-meshheading:10908083... | lld:pubmed |
| pubmed-article:10908083 | pubmed:meshHeading | pubmed-meshheading:10908083... | lld:pubmed |
| pubmed-article:10908083 | pubmed:meshHeading | pubmed-meshheading:10908083... | lld:pubmed |
| pubmed-article:10908083 | pubmed:meshHeading | pubmed-meshheading:10908083... | lld:pubmed |
| pubmed-article:10908083 | pubmed:meshHeading | pubmed-meshheading:10908083... | lld:pubmed |
| pubmed-article:10908083 | pubmed:meshHeading | pubmed-meshheading:10908083... | lld:pubmed |
| pubmed-article:10908083 | pubmed:meshHeading | pubmed-meshheading:10908083... | lld:pubmed |
| pubmed-article:10908083 | pubmed:meshHeading | pubmed-meshheading:10908083... | lld:pubmed |
| pubmed-article:10908083 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10908083 | pubmed:articleTitle | Plasma norepinephrine and atrial natriuretic peptide in heart failure: influence of felodipine in the third Vasodilator Heart Failure Trial. V-HeFT III investigators. | lld:pubmed |
| pubmed-article:10908083 | pubmed:affiliation | Cardiology Section, Veterans Affairs Medical Center, Nashville, Tennessee, USA. | lld:pubmed |
| pubmed-article:10908083 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10908083 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10908083 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10908083 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10908083 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:10908083 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
